Imagion Biosystems Ltd (IBX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.048x

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has a cash flow conversion efficiency ratio of 1.048x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.27 Million ≈ $-1.60 Million USD) by net assets (AU$-2.16 Million ≈ $-1.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Imagion Biosystems Ltd stock valuation for the company's overall valuation and market capitalisation.

Imagion Biosystems Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imagion Biosystems Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imagion Biosystems Ltd ranked by their cash flow conversion efficiency. Explore IBX cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
BIO-Key International Inc NASDAQ:BKYI	-0.238x
Mercator Limited NSE:MERCATOR	0.000x
AIS Resources Ltd V:AIS	-0.177x
Masivo Silver Corp V:MASS	-10.665x
Andrews Sykes Group plc LSE:ASY	0.226x
Realites PA:ALREA	-0.231x
Prestal Holdings Ltd AU:PTL	-0.192x
Infinity Mining Ltd AU:IMI	-0.021x

Annual Cash Flow Conversion Efficiency for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Ltd from 2014 to 2025. View Imagion Biosystems Ltd (IBX) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$-2.16 Million ≈ $-1.53 Million	AU$-4.04 Million ≈ $-2.86 Million	1.870x	+236.07%
2024-12-31	AU$-2.28 Million ≈ $-1.62 Million	AU$-1.27 Million ≈ $-899.04K	0.557x	-74.65%
2023-12-31	AU$-3.79 Million ≈ $-2.68 Million	AU$-8.32 Million ≈ $-5.88 Million	2.195x	+227.18%
2022-12-31	AU$4.68 Million ≈ $3.31 Million	AU$-8.07 Million ≈ $-5.71 Million	-1.726x	-353.14%
2021-12-31	AU$13.31 Million ≈ $9.41 Million	AU$-5.07 Million ≈ $-3.59 Million	-0.381x	-6.41%
2020-12-31	AU$12.91 Million ≈ $9.14 Million	AU$-4.62 Million ≈ $-3.27 Million	-0.358x	+74.55%
2019-12-31	AU$2.97 Million ≈ $2.10 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.406x	+33.10%
2018-12-31	AU$3.87 Million ≈ $2.74 Million	AU$-8.13 Million ≈ $-5.76 Million	-2.102x	-109.47%
2017-12-31	AU$6.95 Million ≈ $4.92 Million	AU$-6.98 Million ≈ $-4.94 Million	-1.004x	-4289.57%
2016-12-31	AU$11.69 Million ≈ $8.27 Million	AU$-267.26K ≈ $-189.10K	-0.023x	-104.80%
2015-12-31	AU$-8.86 Million ≈ $-6.27 Million	AU$-4.22 Million ≈ $-2.99 Million	0.477x	-22.14%
2014-12-31	AU$-3.97 Million ≈ $-2.81 Million	AU$-2.43 Million ≈ $-1.72 Million	0.612x	--

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research

Market Cap

$2.78 Million

AU$3.92 Million AUD

Market Cap Rank

#29682 Global

#1688 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.05

All Time High

AU$8.60